Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

pengarang

Amy L Sherborne

Joseph P. Neglia

Les Robison

diterbitkan dalam: Clinical Cancer Research

tanggal publikasi: 2016-09-28

bahasa: Inggris

Cites articles 50

Date

Judul

Pengarang

2016-01-01

Analysis of RNA-Seq Data Using TopHat and Cufflinks

Sreya Ghosh, Chon-Kit Kenneth Chan
2015-12-01

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma

Michael Schaapveld, Stijn Krol, Marieke W. J. Louwman
2015-11-18

Germline Mutations in Predisposition Genes in Pediatric Cancer

Dale Hedges, Ching-Hon Pui, Elaine Mardis
2015-07-20

An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?
2015-05-23

Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy

Richard Mitter, Stuart Horswell, Nicolai J Birkbak, Nicholas McGranahan, Charles Swanton, Sharmin Begum, Benjamin Phillimore, Andrew Rowan, Max Salm, Nirupa Murugaesu, Jennifer L Biggs
2015-09-03

Mutational Analysis of Ionizing Radiation Induced Neoplasms

Amy L Sherborne
2015-11-09

Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients
2014-12-27

Structural and sequential context of p53: A review of experimental and theoretical evidence

Rajiv Kumar Kar
2014-10-29

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors
2014-04-17

Unravelling mechanisms of p53-mediated tumour suppression

Stephano S. Mello
2014-03

Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers

Fran Supek, Juan Valcárcel, Ben Lehner, Toni Gabaldón
2013-12-19

Uncovering the role of p53 splice variants in human malignancy: a clinical perspective

Jean-Christophe Bourdon
2013-12-12

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

Andrew Mungall, Cory Y McLean, William A Weiss, Jun S Song, Steven Jones, Hiroyuki Aburatani
2013-08-22

Signatures of mutational processes in human cancer

Jessica Zucman-Rossi, Stian Knappskog, Anne-Lise Børresen-Dale, Marcin Imielinski, Keiran Raine, Carlos Caldas, Elli Papaemmanuil, Jon Teague, Anne Vincent-Salomon, Michael Stratton, P. Andrew Futreal, Sunil R Lakhani, Matthew Meyerson, Barbara Hutter, Marcel Kool, Stefan M. Pfister, Paul A Northcott, Serena Nik-Zainal, David T. W. Jones, Peter F. Stadler, Ralf Küppers, David Langenberger, Helen Davies, Xose S. Puente, Rafael Valdés-Mas
2013-06

The Genotype-Tissue Expression (GTEx) project
2013-01-01

p53 mutations in cancer

Karen Vousden
2013-12-05

Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Les Robison, Melissa M Hudson
2013-06-15

Incidence of second malignancies among patients treated with proton versus photon radiation

Nancy Keating, Nancy J. Tarbell, Torunn I Yock
2012-06-25

The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

Barbara Garmy-Susini, David P. Lane, Jean-Christophe Bourdon, Anne-Catherine Prats
2012-06-01

Mutant p53: one name, many proteins

William A Freed-Pastor, Carol Prives
2012-12-01

Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma

Keisuke Horiuchi
2011-12-06

Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data

Isabelle Janoueix-Lerosey, Valentina Boeva, Emmanuel Barillot, Olivier Delattre, Gudrun Schleiermacher, Kevin Bleakley, Julie Cappo
2011-11-11

Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity

Daniel Aberdam
2011-08-11

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts

Steven Salzberg
2011-04-01

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

Timothy A. Graubert, Jennifer L. Ivanovich, Elaine Mardis, Michelle M Le Beau, Richard K. Wilson, Lucinda Fulton, Kim Delehaunty, Michael D McLellan, Dan Koboldt, Timothy Ley, Catrina Fronick, Heather Schmidt, David Dooling, Jacqueline E Payton, Rakesh Nagarajan, Nobish Varghese, Paul J Goodfellow
2011-05-19

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study

Uri Tabori, David Malkin
2011-06-01

Long-term risks of subsequent primary neoplasms among survivors of childhood cancer

Raoul C Reulen, Julie Kelly, Charles Stiller
2010-09

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

David Altshuler, Kristian Cibulskis, Stacey Gabriel, Aaron McKenna, Mark Joseph Daly, Andrey Sivachenko, Eric Banks, Andrew Kernytsky, Mark DePristo
2010-07-15

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

Wendy Leisenring, Debra L. Friedman, Ann C Mertens, Marilyn Stovall, Les Robison
2010-09

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
2009-09-21

Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

Moody D. Wharam, William H. Meyer, James R. Anderson, Douglas S Hawkins
2009

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

Mihai Pop, Steven Salzberg, Ben Langmead, Cole Trapnell

Artikel - wd:Q39341353

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut